AR127555A1 - Composiciones y métodos que comprenden dsg2 asociados a enfermedades cardíacas - Google Patents

Composiciones y métodos que comprenden dsg2 asociados a enfermedades cardíacas

Info

Publication number
AR127555A1
AR127555A1 ARP220103004A ARP220103004A AR127555A1 AR 127555 A1 AR127555 A1 AR 127555A1 AR P220103004 A ARP220103004 A AR P220103004A AR P220103004 A ARP220103004 A AR P220103004A AR 127555 A1 AR127555 A1 AR 127555A1
Authority
AR
Argentina
Prior art keywords
dsg2
protein
arrhythmia
treating
compositions
Prior art date
Application number
ARP220103004A
Other languages
English (en)
Spanish (es)
Inventor
Shi Yin Foo
Ryan Edward Tyler
Original Assignee
Arvada Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arvada Therapeutics Inc filed Critical Arvada Therapeutics Inc
Publication of AR127555A1 publication Critical patent/AR127555A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ARP220103004A 2021-11-02 2022-11-02 Composiciones y métodos que comprenden dsg2 asociados a enfermedades cardíacas AR127555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163274707P 2021-11-02 2021-11-02

Publications (1)

Publication Number Publication Date
AR127555A1 true AR127555A1 (es) 2024-02-07

Family

ID=84569745

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103004A AR127555A1 (es) 2021-11-02 2022-11-02 Composiciones y métodos que comprenden dsg2 asociados a enfermedades cardíacas

Country Status (12)

Country Link
US (1) US20240279304A1 (enExample)
EP (1) EP4426430A1 (enExample)
JP (1) JP2024540220A (enExample)
KR (1) KR20240110819A (enExample)
CN (1) CN118369351A (enExample)
AR (1) AR127555A1 (enExample)
AU (1) AU2022382972A1 (enExample)
CA (1) CA3236070A1 (enExample)
IL (1) IL312219A (enExample)
MX (1) MX2024005327A (enExample)
TW (1) TW202334190A (enExample)
WO (1) WO2023081674A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117860721A (zh) * 2023-12-25 2024-04-12 五邑大学 三甲基氯化铵在制备冠状病毒刺突蛋白受体结合结构域的特异性结合剂中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965197A (en) 1987-06-12 1990-10-23 Massachusetts Institute Of Technology Coryneform expression and secretion system
KR100316347B1 (ko) 1998-09-15 2002-08-27 한미약품(주) 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
DE10057397A1 (de) 2000-11-18 2002-05-23 Hella Kg Hueck & Co Vorrichtung zur Ölstandsmessung
DK2147104T3 (en) 2007-05-21 2015-12-14 Danisco Us Inc USING A ASPARAGINPROTEASE- (NSP24) SIGNAL SEQUENCE FOR heterologous protein EXPRESSION
US8324578B2 (en) 2008-09-30 2012-12-04 Apple Inc. Hidden sensors in an electronic device
KR101410845B1 (ko) 2009-09-10 2014-06-23 바이오콘 리미티드 새로운 프로리파제-보바인 트립시노겐 융합 단백질
JP2012107935A (ja) * 2010-11-16 2012-06-07 Mitsubishi Chemicals Corp Ｄｅｓｍｏｇｌｅｉｎ−２蛋白質による脳梗塞の検査方法
RU2632651C2 (ru) 2011-05-11 2017-10-06 Чилдрен'С Медикал Сентер Корпорейшн Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение
EP3568697B1 (en) * 2017-01-13 2022-06-29 The Hospital for Sick Children Method for diagnosis of arrhythmogenic right ventricular cardiomyopathy
CA3202364A1 (en) * 2020-12-15 2022-06-23 Arvada Therapeutics, Inc. Dsg2 compositions and methods for the treatment of covid-19

Also Published As

Publication number Publication date
MX2024005327A (es) 2024-05-21
KR20240110819A (ko) 2024-07-16
EP4426430A1 (en) 2024-09-11
TW202334190A (zh) 2023-09-01
CA3236070A1 (en) 2023-05-11
WO2023081674A1 (en) 2023-05-11
JP2024540220A (ja) 2024-10-31
AU2022382972A1 (en) 2024-05-09
US20240279304A1 (en) 2024-08-22
CN118369351A (zh) 2024-07-19
IL312219A (en) 2024-06-01

Similar Documents

Publication Publication Date Title
Ohba et al. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men
Hall NT-ProBNP: the mechanism behind the marker
Casserly et al. Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent
Vanderheyden et al. Brain and other natriuretic peptides: molecular aspects
Vasile et al. Natriuretic peptides and analytical barriers
Zhou et al. Corin in natriuretic peptide processing and hypertension
Del Ry et al. Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure
Toscana Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations
Semenov et al. Standardization of BNP and NT-proBNP immunoassays in light of the diverse and complex nature of circulating BNP-related peptides
Srivastava et al. Levels of crystallin fragments and identification of their origin in water soluble high molecular weight (HMW) proteins of human lenses
Kongsuwan et al. Activation of several key components of the epidermal differentiation pathway in cattle following infestation with the cattle tick, Rhipicephalus (Boophilus) microplus
Janczarek et al. The influence of selected factors and sport results of endurance horses on their saliva cortisol concentration
AR039629A1 (es) Antagonistas de proteinas mcp
Nagai‐Okatani et al. Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization
Papakonstantinou et al. Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?
Philippou et al. Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain
Tsuk et al. Kv2. 1 channel activation and inactivation is influenced by physical interactions of both syntaxin 1A and the syntaxin 1A/soluble N-ethylmaleimide-sensitive factor-25 (t-SNARE) complex with the C terminus of the channel
Hunter et al. Measurement of the total proANP product in mammals by processing independent analysis
Essop et al. Proteomic analysis of mitochondrial proteins in a mouse model of type 2 diabetes: cardiovascular topics
Ilian et al. Postmortem changes in myofibrillar-bound calpain 3 revealed by immunofluorescence microscopy
Nanaev et al. Immunofluorescent study of heterogeneity in smooth muscle cells of human fetal vessels using antibodies to myosin, desmin, and vimentin
Liu et al. Identification and purification of a novel fish allergen from largemouth bass (Micropterus salmoides)
Tokudome et al. Importance of endogenous atrial and brain natriuretic peptides in murine embryonic vascular and organ development
Khan et al. Dysregulation of metalloproteins in ischemic heart disease patients with systolic dysfunction
Srivastava et al. Crosslinking of human lens 9 kDa gammaD-crystallin fragment in vitro and in vivo